Indication of hepatectomy for cirrhotic patients with hepatocellular carcinoma classified as Child-Pugh class B

被引:15
作者
Nakahara, H [1 ]
Itamoto, T [1 ]
Katayama, K [1 ]
Ohdan, H [1 ]
Hino, H [1 ]
Ochi, M [1 ]
Tashiro, H [1 ]
Asahara, T [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Programs Biomed Res, Div Frontier Med Sci,Dept Surg,Minami Ku, Hiroshima 7348551, Japan
关键词
D O I
10.1007/s00268-005-7750-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
We clarified the indication of partial hepatectomy in hepatocellular carcinoma (HCC) patients with liver cirrhosis classified as Child-Pugh class B. Univariate analysis revealed that adverse prognostic factors were (1) the presence of ascites, (2) elevated total bilirubin (1.5 mg/dl or higher), (3) reduced choline esterase (160 IU/ or lower), (4) elevated alpha-fetoprotein (AFP) (400 ng/ml or higher), (5) microscopic vascular invasion, and (6) non-curative hepatectomy. Microvascular invasion was excluded in the multivariate analysis because this factor could not be predicted before bepatectomy. Multivariate analysis revealed that independent adverse prognostic factors were (1) elevated total bilirubin (1.5 mg/dl or higher), (2) presence of ascites, (3) elevated AFP (400 ng/ml or higher), and (4) non-curative hepatectomy. The overall 5-year survival rate of patients with none of or only one of the four adverse prognostic factors was 45.8%. The overall 5-year survival rate of patients with two or more adverse prognostic factors was only 7.0%. Partial hepatectomy is the first choice of treatment for patients with none of or only one of the four adverse prognostic factors, whereas orthotopic liver transplantation or other conservative treatment should be considered for patients with two or more adverse prognostic factors.
引用
收藏
页码:734 / 738
页数:5
相关论文
共 22 条
[1]   Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan [J].
Arii, S ;
Yamaoka, Y ;
Futagawa, S ;
Inoue, K ;
Kobayashi, K ;
Kojiro, M ;
Makuuchi, M ;
Nakamura, Y ;
Okita, K ;
Yamada, R .
HEPATOLOGY, 2000, 32 (06) :1224-1229
[2]   Hepatocellular carcinoma: Diagnosis and treatment [J].
Befeler, AS ;
Di Bisceglie, AM .
GASTROENTEROLOGY, 2002, 122 (06) :1609-1619
[3]   Liver transplantation for hepatocellular carcinoma [J].
Bismuth, H ;
Majno, PE ;
Adam, R .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :311-322
[4]  
Bruix J, 1997, HEPATOLOGY, V25, P259
[5]   Prognostic prediction and treatment strategy in hepatocellular carcinoma [J].
Bruix, J ;
Llovet, JM .
HEPATOLOGY, 2002, 35 (03) :519-524
[6]  
COUINAUD C, 1954, PRESSE MED, V62, P709
[7]   Hepatocellular carcinoma and cirrhosis - Results of surgical treatment in a European series [J].
Fuster, J ;
GarciaValdecasas, JC ;
Grande, L ;
Tabet, J ;
Bruix, J ;
Anglada, T ;
Taura, P ;
Lacy, AM ;
Gonzalez, X ;
Vilana, R ;
Bru, C ;
Sole, M ;
Visa, J .
ANNALS OF SURGERY, 1996, 223 (03) :297-302
[8]   Living-donor liver transplantation for hepatocellular carcinoma [J].
Kaihara, S ;
Kiuchi, T ;
Ueda, M ;
Oike, F ;
Fujimoto, Y ;
Ogawa, K ;
Kozaki, K ;
Tanaka, K .
TRANSPLANTATION, 2003, 75 (03) :S37-S40
[9]  
*LIV CAN STUD GROU, 2003, GEN RUL RUL CLIN PAT, P2
[10]   Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation [J].
Llovet, JM ;
Fuster, J ;
Bruix, J .
HEPATOLOGY, 1999, 30 (06) :1434-1440